Conviction backed by things in hand: management stakes the next leg of growth on evidence it already possesses, not cond
The model's full reasoning — Q1 2022 call → NOWe need answer YES/NO. Need evaluate based on transcript. Need determine if management expresses clear conviction business stepping up to meaningfully higher level over coming quarters, and grounded in concrete things already in hand/happening, not market conditions etc. Let's parse. Weyerhaeuser Q1 2022. Management comments. Devin: "We continue to make meaningful progress towards multiyear growth targets... balance sheet strong... 2022 off to great start." But is there stated conviction about step-up ahead? They discuss acquisitions, carbon capture project, housing demand. Need see if they say business will be meaningfully bigger/busier/stronger over coming year. They mention "We expect to announce additional carbon capture and storage agreements" but not yet. Timberland acquisition expected to close later in quarter. They have growth strategy. But forward outlook: Q2 Timberlands significantly lower than Q1 but higher than any other quarter since Q4 2018. Wood Products Q2 higher than Q1 excluding price changes. But that's near-term. Is there clear conviction about step-up? Maybe not. They talk about "multi-year growth targets" but not specific step-up. They mention "exciting growth opportunity" acquisition. But conviction? Need see if they ground in concrete things already in hand. They have acquisition of 81,000 acres, carbon capture agreement with Oxy, debt refinancing. But do they say business stepping up? They say "We continue to make meaningful progress towards the multiyear growth targets we announced at our Investor Day last September" - that's aspiration/progress. Not clear conviction about step-up ahead. They also discuss market conditions: housing demand, repair/remodel. They are cautious about lumber prices. They don't say "we expect business to be meaningfully bigger." They say "2022 is off to a great start" but not step-up. They mention "we expect to announce additional carbon capture and storage agreements" - pipeline hopes. They have "agreement with Oxy" but project online 2025/2026, not coming quarters. So no. Need answer NO. But let's ensure.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| INSM | Insmed Incorporated | Q4 2017 | 2018-02-23 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| GPOR | Gulfport Energy Corporation | Q4 2016 | 2017-02-14 | A |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
CUE · Q3 2022 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction that the business is stepping up to a meaningfully higher level, citing the recent $30M PIPE financing, Fast Track designation, emerging clinical data from CUE-101 monotherapy and combination trials, and the derisked Immuno-STAT platform as concrete assets already in hand that support advancing toward 2024 clinical development and potential registration paths. They ground this in present-tense facts such as the SITC data, cash runway extension, first CUE-102 patient dosed, and ongoing trial expansions rather than external market or industry conditions.
BFIN · Q1 2022 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction that the business is stepping up: they have already achieved and exceeded the $40 million quarterly loan growth goal, are targeting $1.125–$1.150 billion in Q2 (with a reach to $1.2 billion by year-end), and expect EPS of $0. 14–$0.16 in Q2 rising $0.03–$0.05 per quarter thereafter, with ROE potentially in the 80s–90s run-rate by early 2023. This conviction rests on concrete, already-real evidence in hand: $45 million loan growth already booked in April 2022 (portfolio now over $1.
ALLY · Q1 2018 → YESThe question is: Does management express CLEAR CONVICTION that the company's business is stepping up to a meaningfully higher level over the coming quarters, AND does it consistently ground that convi...YES Management states clear conviction of a step-up: “we see these metrics meaningfully higher on a year-over-year basis, and that will fully continue over the medium term,” “adjusted EPS growth of 20% to 30% for the year,” “we expect net financing revenue to move higher,” “expect to see acceleration in this line item in Q2 and throughout the rest of 2018,” and “keeps us on the path to delivering our 2018 outlook.” That conviction is grounded in concrete, already-present items: record $9.